EGR3 and breast carcinoma: To investigate the mechanistic basis of the three-gene prognostic signature (EGR3, RECQL4, MMP1) in breast cancer progression, we performed differential expression analysis followed by GO and KEGG pathway enrichment analyses between the two molecular subtypes.